Dyslexia Treatment Market Research Report - Forecast till 2027

Dyslexia Treatment Market Research Report: By Type Of Dyslexia (Phonological Dyslexia, Surface Dyslexia), By Treatment (Drug Class, Tools, Educational Techniques) and By End-User (Hospitals, Home Care, Others) – Forecast to 2027

ID: MRFR/HC/6890-HCR | February 2021 | Region: Global | 111 pages

Dyslexia Treatment Market Overview

The Dyslexia Treatment Market is projected to generate a higher market value of USD 26,884.5 Million by the end of the year 2025. Further, the global market has estimated to reach a CAGR of 6.5% for the forecast period. Dyslexia is a condition where the patient faces difficulty in writing, reading, and remembering unfamiliar or difficult words. Basically, dyslexia is a neurological learning disorder that can be found in various regions of people. Dyslexia can be treated at an early age of the children by employing special teaching techniques. Even there are various online programs and Dyslexia International organizations that improve the reading and learning problems of dyslexia disorder. Hence, these many collective efforts for dyslexia are fueling the growth of the Dyslexia Treatment Market.

The Dyslexia Treatment Market is growing with the phonological dyslexia type as it is characterized by experiencing difficulty in reading difficult words or unfamiliar words. On the other hand, surface dyslexia is propelling the growth of the Dyslexia Treatment Market. It is characterized by difficulty reading and remembering difficult words or unfamiliar words. Moreover, the Dyslexia Treatment Industry is propelling its growth due to the increasing demands of psychiatric Institutions like mental hospitals, mental health units, simply asylums, or mental asylums and counseling centers.

The Dyslexia Treatment Market is driving growth due to the presence of various treatment methods like an advanced drug for the treatment of central nervous disorder. Moreover, the global market is improving the writing and reading abilities of all age groups with the help of the availability of online programs and different developed apps. The Dyslexia Treatment Industry is thriving due to the increasing use of visualizing tools that help people with dyslexia understand mathematical problems and memorize words. Further, the educational techniques are projected to be the largest growing segment for the research period due to a large number of education centers and schools for dyslexia children.

COVID-19 Impact Analysis

The ongoing COVID-19 pandemic has introduced many new social distancing rules and shutdown of various regions, which has affected the transportations and workforce. Automatically, it has affected the growth of the Dyslexia Treatment Industry. During the COVID-19 period, it has impacted the growth of the global market as many investors refused to invest in this industry.

Further, the Dyslexia Treatment Market has adopted several safety measures with implying various promotional ideas and strategies to the global market. Hence, the continuous efforts of the key players have expected to meet at the higher Dyslexia Treatment Industry Share for the forecast period.

Market Dynamics

Major Driver Of the global Market

The global Dyslexia Treatment Industry is driving its growth due to the use of special tools such as memory aids, visual techniques, and computers for the practice of math. Moreover, the introduction of individual education programs is another major factor for the growth of the global market.

The global Dyslexia Treatment Market Growth is propelling due to the exponential number of dyslexia children. The US-based dyslexia center reports that 30 million to 50 million children had dyslexia in India, and nearly 15 in 100 students are found to be dyslexic every year in India. Moreover, the report has also mentioned the Canadian region had more than 15% of the students with dyslexia in 2016.

Opportunity for the Global Market

The increasing research in biotechnology and pharmaceutical industries is having various Dyslexia Treatment Industry Growth aspects, which is bringing more opportunities for the global market.

Moreover, the global Dyslexia Treatment Market brings lucrative opportunities due to the increasing government support for the different technologically advanced memory devices and learning devices development.

Market Restraints

The global Dyslexia Treatment Market Outlook might face major restraints due to the lack of awareness among people about dyslexia and its symptoms. Another major restraint can be not having an early diagnosis of dyslexia.

So, the global Dyslexia Treatment Industry has involved major key players in promoting their marketing strategies to improve awareness among the people.

Market Growth Challenges

The global Dyslexia Treatment Market Outlook might face challenges due to the limited operating marketing revenue opportunities for targeted therapies research and development. Along with that, the global market might experience challenges due to the low healthcare budget.

Moreover, the global market is adopting safety measures and promotional ideas to enhance the Dyslexia Treatment Market Value for the forecast period.

Cumulative Growth Analysis

The Dyslexia Treatment Market Forecast report explains that the Asia-Pacific region is predicted to be the fastest-growing market in the forecast period due to the rising demands for dyslexia treatment methods and the lack of early diagnosis of dyslexia disorder.

Further, the global market report has explained that the global market is showing significant growth in generating the Dyslexia Treatment Industry Value in the present year and has aimed to meet at higher growth or the forecast period.

Market Segment Overview

By Type Of Dyslexia

On the basis of the type of dyslexia segment, the global Dyslexia Treatment Market has been classified into Surface Dyslexia and Phonological Dyslexia.

Among these, phonological dyslexia is expected to be the fastest-growing and largest segment for the forecast period because the research says that a large number of children are experiencing difficulty in understating languages and reading the text.

By Treatment:

The global Dyslexia Treatment Industry has been segmented into tools, drug classes, and educational techniques based on the treatment segment.

Out of these, the drug class segment is predicted to generate the largest Dyslexia Treatment Industry Share for the assessment period due to the increasing health ministry funding to enhance the therapeutic drugs for the treatment of occurring symptoms of dyslexia.

By End-User:

On the basis of the end-users segment, the global Dyslexia Treatment Market has been segmented into home care, psychiatric institutions or hospitals, and others (training institutes and special schools).

Among these, the home care segment is expected to be the fastest-growing segment due to the demands of techniques that are used to treat dyslexia at home.

Regional Analysis

Based on the regional segmentation, the global Dyslexia Treatment Industry has been classified into America, Europe, Asia Pacific, and the Middle East and Africa.

Among all, the American market is dominating the largest Dyslexia Treatment Market Size for the forecast period. Here, the countries like Canada and the US are having the largest number of dyslexia adults, which is propelling the growth of the global Dyslexia Treatment Industry. If looking into the American, nearly 14.5 to 43.5 million adults and children are facing dyslexia, which is also enhancing the regional growth of the global market.

Competitive Landscape Analysis

According to the Dyslexia Treatment Market Trends, the global market is growing with the efforts of the significant key players of the market. These significant key players are:

  • Micro Labs (India)

  • Pfizer Inc. (US)

  • Jubilant Cadista (US)

  • Novartis AG (UK)

  • Srikem Labs (India)

  • Purdue Pharma (US)

  • Gangwal Chemicals Pvt. Ltd (India)

  • Wallace Pharmaceuticals Ltd (US)

  • RPG Life Sciences Ltd (India)

  • Teva Pharmaceutical Industries Ltd (Israel)

  • Cian Healthcare Pvt Ltd (India)

  • GlaxoSmithKline (UK)

  • Eli Lilly & Company (US).

The global key players play an important role in the Dyslexia Treatment Market Trends as they adopt various techniques and strategies to thrive the Dyslexia Treatment Market Size in the forecast period.

Recent Developments

  • In October 2017, the physiological cause for dyslexia had been discovered by the French scientists that could be a potential treatment. Here, it has been identified that dyslexia patients have tiny light receptor cells in the center of each eye. Hence, this research has been helpful in developing a better treatment for dyslexia patients.

Report Overview

The Dyslexia Treatment Market Analysis report has highlighted the brief analysis of the market performance and the deeper insight view of the global market through the qualitative and quantitative analysis method. This present report has involved the primary and secondary research methods to measure the growing performance of the global market. Moreover, the global market has given light on the market dynamics, market segment, regional analysis, and market overview in terms of value and size of the global market.

Along with that, the Dyslexia Treatment Industry Analysis report has given the focus on the present competitions among the key players of various regions who are adopting various strategies to enhance the growth of the global market.

Segmental Table:

By Types of Dyslexia:

  • Surface Dyslexia,

  • Phonological Dyslexia

By Treatment:

  • Tools,

  • Drug class,

  • Educational techniques

By End-Users:

  • Home care,

  • Psychiatric institutions or hospitals,

  • Others (training institutes and special schools)

Report Scope:
Report Attribute/Metric Details
  Market Size   2025: USD 26,884.5 Million
  CAGR   2019-2025: 6.5%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type Of Dyslexia, Treatment, Route Of Administration, And End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Jubilant Cadista (US), Pfizer Inc (US), Micro Labs (India), Gangwal Chemicals Pvt. Ltd (India), Srikem Labs (India), Novartis AG (UK), Purdue Pharma (US), RPG Life Sciences Ltd. Cian Healthcare Pvt. Ltd (India), GlaxoSmithKline (UK), Teva Pharmaceutical Industries Ltd (Israel), Eli Lilly & Company (US), and Wallace Pharmaceuticals Ltd (US)
  Key Market Opportunities   Biotechnology and pharmaceutical industries
  Key Market Drivers

  • Rising geriatric population across the globe
  • Rising need for pain relief drugs for chronic pain\r\n

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    dyslexia treatment market is projected grow at approximately 6.5% CAGR during the assessment period (2019-2025).

    The valuation of the dyslexia treatment market is estimated to increase to USD 26,884.5 MN by the end of 2025.

    Growing awareness among populaces, increasing research in pharmaceutical and biotechnology industries, and growing government support for the development of therapeutic drugs to treat the symptoms caused by dyslexia are the major tailwinds pushing the growth of the global dyslexia treatment market.

    North America holds the largest share in the dyslexia treatment market, followed by Europe and the Asia Pacific, respectively.

    Pfizer Inc. (US), Jubilant Cadista (US), Micro Labs (India), Srikem Labs (India), Gangwal Chemicals Pvt. Ltd (India), Novartis AG (UK), RPG Life Sciences Ltd. Cian Healthcare Pvt. Ltd (India), Purdue Pharma (US), GlaxoSmithKline (UK), Eli Lilly & Company (US), Teva Pharmaceutical Industries Ltd (Israel), and Wallace Pharmaceuticals Ltd (US), are some of the major players operating in the global dyslexia treatment market.

    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.